Date of Original Release: July 15, 2024
Date of Expiration: July 15, 2027
Estimated Time of Completion: 3.0 Hours

Target Audience
Dermatologists and others involved in the delivery of dermatologic care.

Statement of Need
The American Academy of Dermatology bases its CME activities on identified professional practice gaps, the educational needs which underlie these gaps, and emerging clinical research findings as these relate to dermatology. Learners should reflect upon clinical and scientific information presented in this CME activity and determine the need for further study.

Learning Objectives
Following participation in this activity, the learner should be able to:

• Define key concepts related to Artificial Intelligence (AI) and related technologies.
• Describe how AI, and related technologies, are developed, how they are currently used, and the potential limitations of these applications and identify opportunities for Dermatologists to participate in the development, design, and deployment of these tools.
• Assess the legal and ethical implications of AI and related technologies and the unique challenges Dermatology faces with the emergence of these applications.

Accreditation Statement
The American Academy of Dermatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

AMA PRA Credit Statement
The American Academy of Dermatology designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credit^TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Instructions to Claim Credit
To Claim CME credit for this activity, the learner must complete the post-activity evaluation survey.

Planners
Ivy Lee, MD, FAAD
California Institute of Technology
Pasadena, CA

Roberto Novoa, MD, FAAD
Departments of Pathology & Dermatology
Stanford University
Palo Alto, CA

Faculty
Albert S. Chiou, MD, FAAD
Stanford University Medical School
Redwood City, CA

Roxana Daneshjou, MD, PhD, FAAD
Biomedical Data Science and Dermatology
Stanford University
Stanford, CA

Edwin Dovigi, MD
Department of Dermatology
University of Pittsburgh
Pittsburgh, PA

Justin Ko, MD, MBA, FAAD
Stanford Medicine
Stanford, CA

Joseph C. Kvedar, MD, FAAD
Massachusetts General Hospital Medical School
Harvard University
Boston, MA

Ivy Lee, MD, FAAD
California Institute of Technology
Pasadena, CA

Roberto Novoa, MD, FAAD
Departments of Pathology & Dermatology
Stanford University
Palo Alto, CA

Veronica Rotemberg, MD, FAAD
Dermatology Imaging Informatics Program
Memorial Sloan Kettering Cancer Center
New York, NY

Daniel Schlessinger, MD
Mohs Surgery and Cosmetics Fellow
Northwestern University
Department of Dermatology
Chicago, IL

Reviewer

Trilokraj Tejasvi, MD, MBBS
Deptartment of Dermatology
University of Michigan
Ann Arbor, MI

Staff
Dustin Herlich, MA
Manager, Digital Learning
Rosemont, IL

Melinda Keske
Senior Coordinator, Digital Learning
Rosemont, IL

Allen McMillen, MS
Associate Director, Research & Operations

Christine Presta, BS, FACEHP
Director, Digital Learning

Jennifer Thompson, MS, FACEHP
Director, Education

Disclosures

All other planners, speakers, reviewers, and staff for this activity have no relevant financial relationships with ineligible companies (formerly known as commercial interests).

Conflict Mitigation Statement
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the American Academy of Dermatology has implemented mechanisms, prior to the planning implementation of this activity, to identify and mitigate conflicts of interest for all individuals in a position to control the content.

Unapproved Use Disclosure
The American Academy of Dermatology requires CME faculty/authors to disclose to learners when products or procedures are being discussed are off-label (not approved for the indications being discussed), unlabeled (not approved for any indications), experimental and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these products/procedures. If you have questions, contact the medical affairs department of the manufacturer for the most recent approval information. Faculty/authors of this activity may be discussing information about pharmaceutical agents that is outside of the U.S. Food and Drug Administration approved labeling.

Disclaimer
The American Academy of Dermatology (AAD) is not responsible for statements made by the author(s). Statement or opinions expressed in this activity reflect the views of the author(s) and do not reflect the official policy of the AAD. The information provided in this CME activity is for continuing education purposes only, is not intended to establish a standard of care, and is not meant to substitute for independent medical judgment of a health provider relative to the diagnostic, management and treatment options of a specific patient’s medical condition. 

No Medical Advice
The information in this publication by the American Academy of Dermatology or any third party should not be considered medical advice and is not intended to replace consultation with a qualified dermatology professional. The American Academy of Dermatology does not answer specific medical questions or refer people to a particular dermatology professional.

Contact Information
For the American Academy of Dermatology Member Resource Center, please call (866) 503-7546.